AU7315900A - Chemokine/cytokine expression inhibitors - Google Patents

Chemokine/cytokine expression inhibitors

Info

Publication number
AU7315900A
AU7315900A AU73159/00A AU7315900A AU7315900A AU 7315900 A AU7315900 A AU 7315900A AU 73159/00 A AU73159/00 A AU 73159/00A AU 7315900 A AU7315900 A AU 7315900A AU 7315900 A AU7315900 A AU 7315900A
Authority
AU
Australia
Prior art keywords
chemokine
cytokine expression
expression inhibitors
inhibitors
cytokine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73159/00A
Inventor
Masami Isaka
Yasuhiko Kawano
Tatsumi Matsumoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU7315900A publication Critical patent/AU7315900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU73159/00A 1999-09-20 2000-09-19 Chemokine/cytokine expression inhibitors Abandoned AU7315900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP26627999 1999-09-20
JP11/266279 1999-09-20
PCT/JP2000/006377 WO2001021177A1 (en) 1999-09-20 2000-09-19 Chemokine/cytokine expression inhibitors

Publications (1)

Publication Number Publication Date
AU7315900A true AU7315900A (en) 2001-04-24

Family

ID=17428759

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73159/00A Abandoned AU7315900A (en) 1999-09-20 2000-09-19 Chemokine/cytokine expression inhibitors

Country Status (2)

Country Link
AU (1) AU7315900A (en)
WO (1) WO2001021177A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW304878B (en) * 1993-09-21 1997-05-11 Takeda Pharm Industry Co Ltd
AU695377B2 (en) * 1994-09-16 1998-08-13 Takeda Chemical Industries Ltd. Triazolopyridazines process and intermediates for their preparation and their use as medicaments

Also Published As

Publication number Publication date
WO2001021177A1 (en) 2001-03-29

Similar Documents

Publication Publication Date Title
AU4943200A (en) Modified cytokine
AU2001258771A1 (en) -secretase inhibitors
AU2001241078A1 (en) Alpha-amylase activity inhibitors
AU5170900A (en) Cell proliferation inhibitors
AU6111000A (en) Inhibitors of viral helcase
AU1890300A (en) Novel interferon-alpha
AU2965600A (en) Interleukin-20
ZA975986B (en) N-alkoxyadenine derivatives acting as cytokine inhibitors.
AU2001255090A1 (en) Cdk inhibitors having 3-hydroxychromen-4-one structure
AU7125700A (en) Enzyme inhibitors
AU3235100A (en) Prothease inhibitors
GB9924522D0 (en) Enzyme inhibitors
AU5765900A (en) Substituted pyridones having cytokine inhibitory activity
AU1588901A (en) Protease inhibitors
AU1474801A (en) Protease inhibitors
AU1474701A (en) Protease inhibitors
AU1474601A (en) Protease inhibitors
AU3888200A (en) Protease inhibitors
AU4066900A (en) Protease inhibitors
AU7127000A (en) Enzyme inhibitors
AU4715497A (en) Cytokine production inhibitors
AU7127100A (en) Enzyme inhibitors
AU6916100A (en) Helical cytokine zalpha48
AU4322300A (en) Divided buffer
AU7315900A (en) Chemokine/cytokine expression inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase